Peritoneal Lavage on the Incidence of Pancreatic Fistula and Related Complications After Pancreatoduodenectomy
NCT ID: NCT05657366
Last Updated: 2023-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
260 participants
INTERVENTIONAL
2023-05-01
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, the investigators designed a multicenter prospective controlled trial to compare the effects of peritoneal lavage and natural drainage on the incidence of pancreatic fistula and related complications after pancreatoduodenectomy. To study the indications of peritoneal lavage.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chyle Leak After Pancreatic Operation
NCT03127150
Closed Suction Drainage and Natural Drainage of the Pancreatic Duct in Pancreaticojejunostomy
NCT00679952
Post-operative Drainage After Pancreaticoduodenectomy
NCT05270564
Perform Necrotic Cavity Lavage or Not After Debridement of Infected Pancreatic Necrosis
NCT04275466
Modified Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy
NCT03600584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low and medium risk(a-FRS)lavage
alternative pancreatic fistula risk score system,a-FRS Low risk group (0\~5%), medium risk group (\>5%\~20%), lavage
Peritoneal lavage
Continuous abdominal flushing with normal saline
low and medium risk(a-FRS) no lavage
alternative pancreatic fistula risk score system,a-FRS Low risk group (0\~5%), medium risk group (\>5%\~20%), no lavage
No interventions assigned to this group
high risk(a-FRS)lavage
alternative pancreatic fistula risk score system,a-FRS high risk group (\>20%) lavage
Peritoneal lavage
Continuous abdominal flushing with normal saline
high risk(a-FRS)no lavage
alternative pancreatic fistula risk score system,a-FRS high risk group (\>20%) no lavage
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peritoneal lavage
Continuous abdominal flushing with normal saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with resectable tumors evaluated by imaging examination, and patients who plan to undergo pancreatoduodenectomy;
3. Subjects informed consent, understood and were willing to cooperate with the trial protocol, and signed relevant documents.
Exclusion Criteria
2. Intraoperative changes in surgical methods, such as patients with tumor dissemination and only abdominal opening and closing; Or it needs to be resected in combination with other organs;
3. Patients and their families do not understand the treatment implementation plan of this study;
4. Failure to complete follow-up;
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The second affiliated hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
zyeyPDlavage
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.